Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
复制标题
DOI:
10.1097/ccm.0b013e3182653269
复制
发表时间:
2012-12-01
影响因子:
8.8
通讯作者:
Schunemann, Holger
中科院分区:
文献类型:
--
作者:
Jacobi, Judith;Bircher, Nicholas;Schunemann, Holger
Objective: To evaluate the literature and identify important aspects of insulin therapy that facilitate safe and effective infusion therapy for a defined glycemic end point.Methods: Where available, the literature was evaluated using Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) methodology to assess the impact of insulin infusions on outcome for general intensive care unit patients and those in specific subsets of neurologic injury, traumatic injury, and cardiovascular surgery. Elements that contribute to safe and effective insulin infusion therapy were determined through literature review and expert opinion. The majority of the literature supporting the use of insulin infusion therapy for critically ill patients lacks adequate strength to support more than weak recommendations, termed suggestions, such that the difference between desirable and undesirable effect of a given intervention is not always clear.Recommendations: The article is focused on a suggested glycemic control end point such that a blood glucose >= 150 mg/dL triggers interventions to maintain blood glucose below that level and absolutely < 180 mg/dL. There is a slight reduction in mortality with this treatment end point for general intensive care unit patients and reductions in morbidity for perioperative patients, postoperative cardiac surgery patients, post-traumatic injury patients, and neurologic injury patients. We suggest that the insulin regimen and monitoring system be designed to avoid and detect hypoglycemia (blood glucose